NPTX1 inhibits colon cancer cell proliferation through down-regulating cyclin A2 and CDK2 expression

Cell Biol Int. 2018 May;42(5):589-597. doi: 10.1002/cbin.10935. Epub 2018 Feb 6.

Abstract

Colon cancer is the third most common malignancy and one of the leading causes of cancer-associated mortality worldwide. Neuronal pentraxin 1 (NPTX1) is associated with tumor progression in some types of tumors. However, its expression and role in colon cancer has not been yet reported. Here we observed that NPTX1 was down-regulated in colon cancer. Additionally, we explored the functional significance of NPTX1 in colon cancer. We found that over-expression of NPTX1 inhibited colon cancer cell growth by performing MTT, colony formation, Edu corporation assays, and cell cycle analysis. In vivo mouse experiments also confirmed the anti-proliferative role of NPTX1 in colon cancer. Further mechanistic study showed that over-expression of NPTX1 inhibited the expression of cyclin A2 and CDK2 in colon cancer cells, thereby regulating the Rb-E2F signaling. In summary, these findings reveal that NPTX1 suppress the colon cancer cell growth and might serve as a useful potential target for treatment of colon cancer.

Keywords: CDK2; NPTX1; colon cancer; cyclin A2; proliferation.

MeSH terms

  • Animals
  • C-Reactive Protein / metabolism*
  • C-Reactive Protein / physiology
  • Cell Line, Tumor
  • Cell Proliferation
  • Colonic Neoplasms / metabolism*
  • Colonic Neoplasms / pathology
  • Cyclin A2 / metabolism*
  • Cyclin-Dependent Kinase 2 / metabolism*
  • Down-Regulation
  • Humans
  • Mice
  • Mice, Nude
  • Nerve Tissue Proteins / metabolism*
  • Nerve Tissue Proteins / physiology
  • Xenograft Model Antitumor Assays

Substances

  • CCNA2 protein, human
  • Cyclin A2
  • Nerve Tissue Proteins
  • neuronal pentraxin
  • C-Reactive Protein
  • CDK2 protein, human
  • Cyclin-Dependent Kinase 2